INU-101
INU-101 is a potent, selective and orally active 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1 inhibitor. INU-101 has highly potent inhibitory activity in mouse, monkey and human 11β-HSD1, derived from liver microsomes. INU-101 can enhance insulin sensitivity and lower the fasting blood glucose level. INU-101 can be used for the research of metabolic disease, such as diabetes[1].
Product Specifications
CAS Number
1513828-41-5
UNSPSC
12352005
Target
11β-HSD
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
NC([C@]12C[C@@H](C3)C(NC(C(C)(C)NS(=O)(C4=C(C=CC=C4)F)=O)=O)[C@@H](C[C@@H]3C2)C1)=O
Molecular Formula
C21H28FN3O4S
Molecular Weight
437.53
References & Citations
[1]Hong SP, et al. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101. Eur J Pharmacol. 2018 Sep 15;835:169-178.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
219415 100 µL
ApoA1, NT (APOA1, Apolipoprotein A-I, Apolipoprotein A1, Truncated Apolipoprotein A-I, Apolipoprotein A-I (1-242) ) discontinued
Sign In for Pricing
View Details